Health news

Last update (UTC): 05:46 - 15/01/2026

The Lancet

[Editorial] Responding to declining global fertility rates

00:00 - 10/01/2026
www.thelancet.com
  View item as page
The levying of a 13% tax on condoms sold in China from Jan 1 is the country's latest policy aimed at reversing its falling total fertility rate (TFR; the average number of children a woman might expect to have in her lifetime); additionally, couples can claim cash payments of 3600 yuan (US$500) a year for each child younger than 3 years, as part of a scheme announced in July, 2025. China is one of more than half of all countries where the TFR is below 2·1 births per woman, the level required to keep the population stable.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00034-6/fullt

[Comment] Zoliflodacin shows benefit as an oral treatment for uncomplicated gonorrhoea

00:00 - 11/12/2025
www.thelancet.com
  View item as page
Neisseria gonorrhoeae inexorably develops resistance to antimicrobials used for treatment. The discovery of novel antimicrobials to treat gonorrhoea is a global priority and antimicrobial-resistant N gonorrhoeae has been identified as an urgent public health threat.1,2 Ceftriaxone remains the primary recommended regimen for gonorrhoea treatment globally. However, reports from China, Cambodia, Viet Nam, and the UK, among other countries, signal a rising threat to the preeminent place of ceftriaxone within the gonococcal treatment armamentarium due to decreased susceptibility to ceftriaxone and periodic ceftriaxone treatment failures, highlighting the importance of enhanced global antimicrobial surveillance to monitor resistance trends.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02331-1/fullt

[Comment] A new standard for relapsed or refractory follicular lymphoma

00:00 - 05/12/2025
www.thelancet.com
  View item as page
Despite progress since 2020, including the approval of immunotherapy as third-line treatment, relapsed or refractory follicular lymphoma remains a clinical challenge, particularly among patients with early progression or resistance to anti-CD20-based regimens. Although the combination of lenalidomide and rituximab is a well established, chemotherapy-free option endorsed by international guidelines, outcomes remain suboptimal in high-risk populations, underscoring the need for novel therapeutic strategies.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01965-8/fullt

[Comment] A step forward in the treatment of relapsed or refractory follicular lymphoma

00:00 - 07/12/2025
www.thelancet.com
  View item as page
Follicular lymphoma remains an incurable malignancy characterised by successive relapses. Despite favourable initial responses to front-line therapy, most patients eventually relapse, and lymphoma or treatment-related complications remain the leading cause of death.1 Accumulating evidence shows that the duration of response shortens with each subsequent line of therapy, resulting in progressively reduced progression-free survival and overall survival after each line of treatment.2,3

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02436-5/fullt

[Comment] Is proton therapy a new standard of care for oropharyngeal cancer?

00:00 - 10/01/2026
www.thelancet.com
  View item as page
The study by Steven J Frank and colleagues1 in The Lancet is the first randomised, phase 3 trial comparing intensity-modulated proton therapy (IMPT) with intensity-modulated radiotherapy (IMRT) in patients with oropharyngeal cancer. Support for the role of proton radiotherapy for head and neck cancer has previously come from dosimetric studies,2 as well as retrospective and case–control clinical reports.3–5 A study with early experience from the MD Anderson Cancer Center compared 50 patients treated with IMPT with 100 patients treated with IMRT, finding a significant reduction in acute gastrostomy tube use and severe weight loss with IMPT, but no difference in tumour control.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02639-X/fullt

[Comment] Climate change, migration, displacement, and health: past, present, and future

00:00 - 17/12/2025
www.thelancet.com
  View item as page
The history of human health and migration, the human story, is deeply intertwined with the natural environment. As described by Anthony McMichael,1 pioneering scholar of health and environmental change, the climate is not merely a backdrop to human life, it is embedded in who we are and how we live. Modern human civilisation has been facilitated by the remarkably stable climatic conditions of the Holocene: the past 11 000 years during which century-to-century global average temperatures varied by no more than 1°C.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02587-5/fullt

[Comment] Offline: Watching the watchers (part 5)

00:00 - 10/01/2026
www.thelancet.com
  View item as page
Global Health Watch 7 (GHW7) is an important intervention in the theory and practice of global health, especially at a time of upheaval and uncertainty. (I am writing these words as I listen to the news that US forces have bombed Venezuela's capital, Caracas, and captured, arrested, and indicted the country's dictator-President Nicolás Maduro and his wife, Cilia Flores: the prospects for a rules-based world order have just swerved sharply towards danger.) The co-editors of GHW7, Ron Labonté and Chiara Bodini, have succeeded in offering alternative narratives to challenge prevailing beliefs and assumptions in global health—a discipline that rarely challenges the political and economic foundations of its work.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00027-9/fullt

[World Report] How a refugee crisis revitalised Poland's tuberculosis care

00:00 - 10/01/2026
www.thelancet.com
  View item as page
Poland's approach to diagnostics, treatment, and prevention has been transformed, improving care for both refugees and Poles. Ed Holt reports.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00032-2/fullt

[World Report] AI data centres raise public health concerns

00:00 - 10/01/2026
www.thelancet.com
  View item as page
Surging demand for AI has driven the frenzied construction of data centres, with concern over their health impacts. Faith McLellan reports.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00033-4/fullt

[Perspectives] Rachel Clarke: writing life

00:00 - 10/01/2026
www.thelancet.com
  View item as page
“When I was really little”, says Rachel Clarke, looking back to her days at primary school, “we had to write a book called All About Me. Mine has a picture of me at a desk saying ‘When I grow up, I am going to be a writer of books.’” Clarke has more than fulfilled her childhood ambition and is the author of four books. The Story of a Heart, her account of a cardiac transplant from one child to another, won the UK's 2025 Women's Prize for Non-Fiction. Clarke divides her time equally between writing and work as a palliative care specialist in the UK.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00001-2/fullt

More

The Lancet Online

[Review] Glucagon-like receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits

00:00 - 14/01/2026
www.thelancet.com
  View item as page
GLP-1 receptor agonists were initially developed to treat type 2 diabetes and have had a transformative effect on its therapy, and are highly effective for glycaemic control, with the added benefit of bodyweight reduction and a low risk of causing hypoglycaemia. GLP-1 receptor agonists reduce risks for major adverse cardiovascular events (eg, non-fatal myocardial infarction, stroke, and cardiovascular death), and the risk of admission to or treatment within hospital for heart failure. These drugs reduce albuminuria and slow the decline in estimated glomerular filtration rate over time, therefore delaying or preventing kidney failure.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02105-1/fullt

[Comment] Yellow fever vaccine minimum fractional dosing does not extend to infants

00:00 - 13/01/2026
www.thelancet.com
  View item as page
Yellow fever vaccine was among the first successful human vaccines to be invented and has been in use for over 80 years. The vaccine is made by culture in eggs, a process with limited capacity that cannot be rapidly scaled up in response to outbreaks. The global stockpile of yellow fever vaccine for outbreak response is 6 million doses.1 In 2016, during yellow fever outbreaks in Angola and the Democratic Republic of the Congo, the global stockpile of yellow fever vaccine was almost exhausted twice.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02364-5/fullt

[Articles] Deaths potentially averted by small changes in physical activity and sedentary time: an individual participant data meta-analysis of prospective cohort studies

00:00 - 13/01/2026
www.thelancet.com
  View item as page
Small and realistic increases in MVPA of 5 min/day might prevent up to 6% of all deaths in a high-risk approach and 10% of all deaths in population-based approach. Reducing sedentary time by 30 min/day might prevent a smaller, but still meaningful, proportion of deaths in the two risk scenarios.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02219-6/fullt

[Comment] Targeting MET-mediated TKI resistance in EGFR-mutant NSCLC

00:00 - 13/01/2026
www.thelancet.com
  View item as page
The management of advanced non-small-cell lung cancer (NSCLC) with activating mutations in EGFR has evolved over the past 20 years. Whether used alone, or in combination with chemotherapy or the bispecific anti-EGFR MET antibody amivantamab, third-generation EGFR tyrosine kinase inhibitors (TKIs), such as osimertinib, are the backbone of treatment. Repeat tissue biopsies following progression on EGFR TKIs identify targetable genomic and histological changes driving TKI resistance in a subset of patients.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02116-6/fullt

[Articles] Low-dose yellow fever vaccination in infants: a randomised, double-blind, non-inferiority trial

00:00 - 13/01/2026
www.thelancet.com
  View item as page
Compared with the standard yellow fever vaccine dose, a dose of 500 IU did not meet the non-inferiority criterion, suggesting that minimum dose requirements in adults are not generalisable to infants. Therefore, standard yellow fever doses should be used for infants in the routine WHO Expanded Programme on Immunization.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02069-0/fullt

[Articles] Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trial

00:00 - 13/01/2026
www.thelancet.com
  View item as page
The savolitinib–osimertinib combination improved PFS versus chemotherapy in patients with EGFR mutation-positive, MET-amplified NSCLC that had progressed on EGFR TKI therapy, while maintaining a favourable tolerability profile. This regimen offers a potential oral treatment option for this biomarker-selected population.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01811-2/fullt

[Seminar] Tetanus

00:00 - 13/01/2026
www.thelancet.com
  View item as page
Tetanus, although preventable by a highly effective vaccine, continues to cause 30 000–50 000 deaths annually. Global mortality has fallen substantially since the 1980s due to widespread vaccination efforts, yet adult disease persists, especially among those with weakened immune response, diabetes, and people who inject drugs. Diagnosis is still clinical, and management combines wound debridement, antibiotics, and antitoxin. However, key questions about prevention, diagnosis, and management remain unanswered.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01579-X/fullt

[Comment] Vaccine hesitancy: an evolving challenge

00:00 - 12/01/2026
www.thelancet.com
  View item as page
In 2015, WHO defined vaccine hesitancy as a “delay in acceptance or refusal of vaccines despite availability of vaccination services”.1 More recently, it has been argued that the concept should be redefined as a “psychological state of indecisiveness that people may experience when making a decision regarding vaccination”,2 thereby distinguishing hesitancy from the final vaccination decision. Indeed, although hesitancy remains an internal state of indecision preceding the behavioural outcome related to vaccination, it is the actual choice a person makes about vaccination (ie, acceptance or refusal) that represents the behaviour itself.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02601-7/fullt

[Correspondence] Ebola and health-care providers: the case for preventive vaccination

00:00 - 12/01/2026
www.thelancet.com
  View item as page
The sixteenth Ebola virus disease outbreak declared on Sept 4, 2025, in Bulape Health Zone, DR Congo, underscores the persistent vulnerability of health-care providers during the onset of epidemics.1

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02459-6/fullt

[Articles] Profiling vaccine attitudes and subsequent uptake in 1·1 million people in England: a nationwide cohort study

00:00 - 12/01/2026
www.thelancet.com
  View item as page
Our findings suggest that most COVID-19 vaccine hesitancy was rooted in concrete concerns that can be addressed and successfully overcome with time and increasing availability of information. These findings should help future vaccination roll-outs to encourage vaccine acceptance.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01912-9/fullt

More

healthtechmagazine.net

Checklist: 4 Basic Components to Make AI Work for Organizations

16:51 - 14/01/2026
healthtechmagazine.net
  View item as page
Organizations across industries continue to explore how to fully incorporate artificial intelligence into their workflows. Ben Castleton, principal consultant for data quality at CDW, breaks down the technical components necessary for AI to operate in an enterprise to four essential parts: Click the banner below to read the new CDW Artificial Intelligence Research Report.

https://healthtechmagazine.net/article/2026/01/checklist-4-basic-components-make

The Growing Role of AI Agents in Healthcare

15:36 - 13/01/2026
healthtechmagazine.net
  View item as page
Agentic artificial intelligence is reshaping how some healthcare organizations coordinate care, streamline patient journeys and expand access to critical services. It’s not just a passive tool; it’s supporting information analysis and orchestrating complex workflows across clinical and administrative environments, including improving screening pathways and easing care transitions. “By stabilizing IT infrastructure, agentic AI helps lay the foundation for more advanced, front-end automation,” says Mutaz Shegewi, senior research director for worldwide healthcare provider AI, platforms and...

https://healthtechmagazine.net/article/2026/01/growing-role-ai-agents-healthcare

How Health Systems Can Address Security Tool Sprawl

14:37 - 12/01/2026
healthtechmagazine.net
  View item as page
Strong identity and access management is an integral part of zero-trust security, but security teams may may be using too many tools to address this important pillar. Read on to discover how security tool sprawl came to be and how organizations can better address it to simplify and streamline their systems. Click the banner below to read the recent CDW Cybersecurity Research Report.

https://healthtechmagazine.net/article/2026/01/how-health-systems-can-address-se

Build a Security Posture That Helps Health Systems Bounce Back

17:03 - 07/01/2026
healthtechmagazine.net
  View item as page
As technology has become a foundational element for healthcare organizations, cyber resilience has become an essential objective for their continued operation, IT experts said at a recent CDW Executive SummIT in Las Vegas. “There are three key principles for resilience: being able to predict, overcome and recover from an attack,” said Hector Cabrera, cybersecurity architect at Cisco Systems, who spoke during a panel at the event. “In business, that helps us meet our key performance indicators as well as keep employee trust and customer trust.” Members of the panel on which Cabrera spoke...

https://healthtechmagazine.net/article/2026/01/build-security-posture-helps-heal

5 Questions to Ask About Liquid Cooling Technologies

15:05 - 07/01/2026
healthtechmagazine.net
  View item as page
As healthcare organizations continue to adopt artificial intelligence to increase staff productivity and to improve clinical workflows, patient experiences and health outcomes, more strain will be put on data centers. To accommodate this trend as well as the rise in extreme weather events, healthcare organizations need a modern approach to cooling. Traditional data centers relied on air-based cooling. For AI, experts say that organizations will likely need to upgrade to a liquid cooling system. Here are five questions to ask about liquid cooling technologies: RELATED: Here are the four AI...

https://healthtechmagazine.net/article/2026/01/5-questions-ask-about-liquid-cool

What Healthcare Organizations Should Know About Advanced Persistent Threats

11:43 - 06/01/2026
healthtechmagazine.net
  View item as page
At this point, healthcare organizations are unfortunately more than familiar with ransomware — it’s not a matter of if but when. Providers are expected to stay vigilant and enhance their cyber resilience. But what happens when an attack isn’t a quick hit? What happens when a malicious actor or group has entered your network undetected, through stolen credentials or any type of backdoor access such as a zero-day vulnerability, and is just lying in wait? Then, after they’ve attacked once, what happens if they never lose that access and attack again? These are advanced persistent threats (APTs...

https://healthtechmagazine.net/article/2026/01/what-healthcare-organizations-sho

5 Questions About Security Debt for Healthcare Organizations

15:36 - 05/01/2026
healthtechmagazine.net
  View item as page
Technical debt is the accumulation of future costs that come with every IT product in your portfolio. For many IT managers, managing technical debt is a careful balancing act to ensure expenditures are predictable and problems are avoided. Security debt is a variation on technical debt — and a bigger problem in healthcare. Click the banner below to read the recent CDW Cybersecurity Research Report.

https://healthtechmagazine.net/article/2026/01/5-questions-about-security-debt-h

CMS Aims To Improve Patient Data Accessibility With AI

18:51 - 29/12/2025
healthtechmagazine.net
  View item as page
While more patient data is collected every day in the healthcare industry, patients’ access to that data is still lacking. To address this issue, the Centers for Medicare & Medicaid Services (CMS) wants to make patients’ medical data more accessible in real time, enabling patients to be better informed about their health and care options, according to its deputy administrator and chief of staff. Speaking at a NVIDIA GTC event in Washington, D.C., recently, Stephanie Carlton said the Trump administration is working with the healthcare industry to improve data accessibility rather than...

https://healthtechmagazine.net/article/2025/12/cms-aims-improve-patient-data-acc

Healthcare Deals 2025: Notable Mergers & Acquisitions Activity

15:31 - 23/12/2025
healthtechmagazine.net
  View item as page
Mergers and acquisitions among hospitals and health systems recovered in Q3 compared with the first half of 2025, according to a new report from Kaufman Hall with 15 announced transactions. The company anticipates an uptick in M&A activity heading into Q4. “Now that the One Big Beautiful Bill has passed, hospitals and health systems have more policy clarity to inform their growth strategies,” said Anu Singh, managing director at Kaufman Hall, in the introduction to the report. “We expect that organizations will continue to seek resilience and growth by investing beyond the hospital and...

https://healthtechmagazine.net/article/2025/04/mergers-and-acquisitions-overview

What Healthcare Organizations Need To Know About the Recent Microsoft Licensing Changes

13:42 - 22/12/2025
healthtechmagazine.net
  View item as page
On November 1, Microsoft implemented its new pricing approach for online services purchased through its volume licensing programs. While the change won’t take place for organizations until their next agreement renewal unless they purchase new online services, it’s important for healthcare organizations to have a plan in place when that time comes. This change impacts services such as Microsoft 365 and Microsoft Intune; business analytics services like Power BI, Power Automate and Power Apps; security services such as Microsoft Defender; and device management services such as Active Directory...

https://healthtechmagazine.net/article/2025/12/what-healthcare-organizations-nee

GP Online

GP News Update: Young GP partners in freefall, PCN breach notice fears, AI books imaginary appointment

16:27 - 14/01/2026
www.gponline.com
  View item as page
Catch up quickly with our weekly round-up of key news stories for general practice.

https://www.gponline.com/gp-news-update-young-gp-partners-freefall-pcn-breach-no

GP job shortage among key threats to neighbourhood rollout, officials warn

14:37 - 14/01/2026
www.gponline.com
  View item as page
Upheaval in ICBs and a failure to create jobs to bring newly-qualified GPs into the NHS workforce are major threats to the rollout of neighbourhoods, a government document warns.

https://www.gponline.com/gp-job-shortage-among-key-threats-neighbourhood-rollout

How prioritising UK graduates will transform competition for GP training

11:26 - 14/01/2026
www.gponline.com
  View item as page
Government plans to prioritise UK medical graduates for specialty training could guarantee almost all suitable UK applicants for general practice training are successful, NHS figures suggest.

https://www.gponline.com/prioritising-uk-graduates-will-transform-competition-gp

Unrealistic to expect immediate NHS savings from neighbourhoods, GPs warn

16:10 - 13/01/2026
www.gponline.com
  View item as page
Expecting neighbourhoods to deliver immediate savings to the NHS is unrealistic, GPs have warned.

https://www.gponline.com/unrealistic-expect-immediate-nhs-savings-neighbourhoods

Vote for MIMS Learning to win the Learning Giveback Award

10:00 - 14/01/2026
www.gponline.com
  View item as page
MIMS Learning's Targeting Health Inequalities has been shortlisted in the Learning Awards 2026 - here's how you can vote to help it win.

https://www.gponline.com/vote-mims-learning-win-learning-giveback-award/article/

Practices could face breach notices over PCN shape, GPs fear

09:59 - 13/01/2026
www.gponline.com
  View item as page
PCNs or member practices could be served contract breach notices if their network fails to meet geographical requirements set by NHS England as neighbourhoods take shape, GPs fear.

https://www.gponline.com/practices-face-breach-notices-pcn-shape-gps-fear/articl

Government launches legislation to prioritise UK medical graduates

22:30 - 12/01/2026
www.gponline.com
  View item as page
UK medical graduates could be given greater priority for specialty training - including in general practice - in future as the government prepares to table legislation in parliament.

https://www.gponline.com/government-launches-legislation-prioritise-uk-medical-g

Young GP partners in freefall as risk and uncertainty take toll

18:13 - 09/01/2026
www.gponline.com
  View item as page
General practice in England has lost almost 700 full-time equivalent GP partners since the last general election - but numbers of younger partners in particular are in freefall, raising major questions over the profession's future.

https://www.gponline.com/young-gp-partners-freefall-risk-uncertainty-toll/articl

NHS has 10 years to avert private sector threat to GPs

11:10 - 12/01/2026
www.gponline.com
  View item as page
General practice must be rebuilt over the coming decade around its core strengths including continuity, comprehensiveness and person-centred care to avoid being ‘hollowed out by private medicine’, a policy expert has warned.

https://www.gponline.com/nhs-10-years-avert-private-sector-threat-gps/article/19

Transcript: New RCGP chair Dr Victoria Tzortziou Brown on her key priorities

09:43 - 12/01/2026
www.gponline.com
  View item as page
A transcript of Talking General Practice’s recent interview with the new RCGP chair where she talked about how to restore joy and pride in general practice

https://www.gponline.com/transcript-new-rcgp-chair-dr-victoria-tzortziou-brown-k

More

Jamanetwork.com

JAMA

00:00 - 13/01/2026
jamanetwork.com
  View item as page

https://jamanetwork.com/journals/jama/fullarticle/2843626

Audio Highlights December 19, 2025

00:00 - 13/01/2026
jamanetwork.com
  View item as page
Listen to the JAMA Editor’s Summary for an overview and discussion of the important articles appearing in JAMA.

https://jamanetwork.com/journals/jama/fullarticle/2843231

State Vaccine Law and Policy—A New Threat to Public Health

00:00 - 13/01/2026
jamanetwork.com
  View item as page
This Viewpoint discusses the importance of understanding the evolution and current trajectory of state-level vaccine requirements for assessing the stability of the nation’s immunization infrastructure.

https://jamanetwork.com/journals/jama/fullarticle/2843189

AI and Health

00:00 - 13/01/2026
jamanetwork.com
  View item as page
JAMA+ AI Editor in Chief Roy Perlis, MD, MSc, spoke with JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH, for JAMA+ AI Conversations.

https://jamanetwork.com/journals/jama/fullarticle/2842978

Use of Controls in Medical Research

00:00 - 13/01/2026
jamanetwork.com
  View item as page
Otho B. Ross Jr., M.D., Charlotte, N. C.

https://jamanetwork.com/journals/jama/fullarticle/2842977

Clarification of Noninferiority Wording and Corrected eFigure

00:00 - 13/01/2026
jamanetwork.com
  View item as page
The Original Investigation titled “Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis: The ADAPT-Sepsis Randomized Clinical Trial,” published December 9, 2024, was corrected to clarify the noninferiority approach described in the Methods section and also to replace eFigure 3 with correct data in the first plot. This article was corrected online.

https://jamanetwork.com/journals/jama/fullarticle/2842969

New Calculator Helps Younger Adults Assess CVD Risk

00:00 - 13/01/2026
jamanetwork.com
  View item as page
A new online calculator may help determine relative risk for long-term cardiovascular disease (CVD) for adults aged 30 to 59. The tool uses metrics including blood pressure, cholesterol levels, and body mass index to compute an individual’s 30-year CVD risk relative to others.

https://jamanetwork.com/journals/jama/fullarticle/2842900

Primary Care Physician Burnout Highest in US

00:00 - 13/01/2026
jamanetwork.com
  View item as page
Results from a new international survey show concerning levels of burnout among primary care physicians (PCPs), especially in the US.

https://jamanetwork.com/journals/jama/fullarticle/2842899

Strides in Cervical Cancer Elimination

00:00 - 13/01/2026
jamanetwork.com
  View item as page
On the first World Cervical Cancer Elimination Day on November 17, the World Health Organization (WHO) shared major milestones in global efforts to protect women and girls from the preventable disease.

https://jamanetwork.com/journals/jama/fullarticle/2842898

Chronic Pain Linked to Hypertension

00:00 - 13/01/2026
jamanetwork.com
  View item as page
Chronic pain may increase the risk of high blood pressure in adults.

https://jamanetwork.com/journals/jama/fullarticle/2842897

More

modernhealthcare.com

Jamanetwork.com Open

Nudging Patients and Clinicians Toward Shared Decision-Making to Address Overuse

00:00 - 14/01/2026
jamanetwork.com
  View item as page
Psychiatry

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2843885

Stress and Burnout in Residency Training

00:00 - 14/01/2026
jamanetwork.com
  View item as page
Medical Education

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2843884

Emoji Use in the Electronic Health Record

00:00 - 14/01/2026
jamanetwork.com
  View item as page
This cross-sectional study investigates rates and characteristics of emoji use in clinical notes within electronic health records.

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2843883

Construction and Application of Directed Acyclic Graphs in Medical Journals

00:00 - 14/01/2026
jamanetwork.com
  View item as page
This cross-sectional study evaluates how directed acyclic graphs are constructed, reported, and applied for statistical adjustment across leading clinical journals.

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2843882

Electronic Intervention for Patient-Managed Benzodiazepine Tapering

00:00 - 14/01/2026
jamanetwork.com
  View item as page
This randomized clinical trial examines whether the benefits of a patient-focused self-management intervention promoting benzodiazepine cessation could be replicated when the intervention was converted from paper and pencil to electronic format.

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2843881

Lyme Disease and Health Care Costs

00:00 - 14/01/2026
jamanetwork.com
  View item as page
This cohort study assesses health care costs associated with Lyme disease, stratified by localized and disseminated disease, among patients in the US.

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2843880

Quality of Life of Parents of Premature Infants

00:00 - 14/01/2026
jamanetwork.com
  View item as page
This systematic review and meta-analysis examines the quality of life among parents of preterm infants and identifies modifiable factors associated with parental quality of life in the postpartum period.

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2843879

Adverse Events After Stereotactic Radiotherapy and Biological Cancer Therapy

00:00 - 14/01/2026
jamanetwork.com
  View item as page
This cohort study examines adverse events associated with stereotactic radiotherapy combined with concurrent biological cancer therapy in patients with metastatic or oligometastatic cancer.

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2843878

Fungal Diseases in Outpatient Community-Acquired Pneumonia

00:00 - 14/01/2026
jamanetwork.com
  View item as page
This cohort study examines the characteristics of adult outpatients with community-acquired pneumonia who underwent diagnostic testing for blastomycosis, coccidioidomycosis, or histoplasmosis and received diagnoses for these diseases.

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2843877

Work Hours, Stress, and Burnout Among Resident Physicians

00:00 - 14/01/2026
jamanetwork.com
  View item as page
This cross-sectional study of US medical residents in high-burnout specialties examines the association of longer work hours with stress, burnout, and self-perceived competency.

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2843876

More